TONIX PHARMACEUTICALS HOLDING CORP. Increase (Decrease) in Prepaid Expense and Other Assets
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.49M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $278.00K, a 54.94% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.00M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.68M, a 391.50% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $3.16M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$3.61M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.57M, a 1059.15% decline from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $164.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.76M 10-Q · filed 2026-08-10 | $2.77M derived: sum of 3 quarters · filed 2026-08-10 | $4.44M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $278.00K 10-Q · filed 2026-05-11 | $1.28M derived: sum of 2 quarters · filed 2026-05-11 | $2.96M derived: sum of 3 quarters · filed 2026-05-11 | $2.82M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.68M derived: sum of 2 quarters · filed 2026-03-12 | $2.54M derived: sum of 3 quarters · filed 2026-08-10 | $3.16M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.54M derived: sum of 2 quarters · filed 2026-08-10 | $2.16M 10-Q · filed 2025-11-10 | -$784.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $483.00K 10-Q · filed 2026-08-10 | -$2.46M derived: sum of 3 quarters · filed 2026-08-10 | -$2.12M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $617.00K 10-Q · filed 2026-05-11 | -$2.33M derived: sum of 2 quarters · filed 2026-05-11 | -$1.99M derived: sum of 3 quarters · filed 2026-05-11 | -$4.35M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$2.60M derived: sum of 2 quarters · filed 2026-03-12 | -$4.97M derived: sum of 3 quarters · filed 2026-03-12 | -$3.61M 10-K · filed 2026-03-12 |
| 2024-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.02M derived: sum of 2 quarters · filed 2025-11-10 | -$670.00K 10-Q · filed 2025-11-10 | $1.09M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.01M 10-Q · filed 2025-08-11 | $750.00K derived: sum of 3 quarters · filed 2025-08-11 | -$2.32M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $1.35M 10-Q · filed 2025-05-12 | $3.12M derived: sum of 2 quarters · filed 2025-05-12 | $50.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.42M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$1.30M derived: sum of 2 quarters · filed 2025-03-18 | -$2.78M derived: sum of 3 quarters · filed 2025-03-18 | -$1.57M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$4.54M derived: sum of 2 quarters · filed 2024-11-12 | -$3.33M 10-Q · filed 2024-11-12 | -$3.92M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$268.00K 10-Q · filed 2024-08-16 | -$857.00K derived: sum of 3 quarters · filed 2024-08-16 | -$4.49M derived: sum of 4 quarters · filed 2024-08-16 |
| 2023-03-31 | $1.21M 10-Q · filed 2024-05-13 | $617.00K derived: sum of 2 quarters · filed 2024-05-13 | -$3.01M derived: sum of 3 quarters · filed 2024-05-13 | -$796.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$589.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.22M derived: sum of 2 quarters · filed 2024-04-01 | -$2.00M derived: sum of 3 quarters · filed 2024-04-01 | $164.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.41M derived: sum of 2 quarters · filed 2023-11-09 | $753.00K 10-Q · filed 2023-11-09 | -$982.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.38M 10-Q · filed 2023-08-10 | $2.65M derived: sum of 3 quarters · filed 2023-08-10 | $3.21M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.17M 10-Q · filed 2023-05-08 | $431.00K derived: sum of 2 quarters · filed 2023-05-08 | $997.00K derived: sum of 3 quarters · filed 2023-05-08 | $3.62M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$1.17M derived: sum of 2 quarters · filed 2023-03-13 | $1.45M derived: sum of 3 quarters · filed 2023-03-13 | -$518.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $566.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $3.19M derived: sum of 2 quarters · filed 2022-11-07 | $1.22M 10-Q · filed 2022-11-07 | $4.41M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $651.00K 10-Q · filed 2022-08-08 | $3.85M derived: sum of 3 quarters · filed 2022-08-08 | $7.58M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$1.97M 10-Q · filed 2022-05-09 | $1.23M derived: sum of 2 quarters · filed 2022-05-09 | $4.96M derived: sum of 3 quarters · filed 2022-05-09 | $4.85M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $6.93M derived: sum of 2 quarters · filed 2022-03-14 | $6.82M derived: sum of 3 quarters · filed 2022-03-14 | $6.86M 10-K · filed 2022-03-14 |
| 2020-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.62M derived: sum of 2 quarters · filed 2021-11-08 | $3.66M 10-Q · filed 2021-11-08 | $4.83M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$74.00K 10-Q · filed 2021-08-09 | $1.09M derived: sum of 3 quarters · filed 2021-08-09 | $615.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $39.00K 10-Q · filed 2021-05-10 | $1.21M derived: sum of 2 quarters · filed 2021-05-10 | $728.00K derived: sum of 3 quarters · filed 2021-05-10 | $15.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $689.00K derived: sum of 2 quarters · filed 2021-03-15 | -$24.00K derived: sum of 3 quarters · filed 2021-03-15 | $1.68M 10-K · filed 2021-03-15 |
| 2019-09-30 | -$479.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.19M derived: sum of 2 quarters · filed 2020-11-09 | $508.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | -$713.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $987.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $1.70M 10-Q · filed 2020-05-12 | |||
| 2018-09-30 | -$295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$332.00K derived: sum of 2 quarters · filed 2019-11-08 | $149.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $444.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $481.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |